Anti-mouse PD-1 (CD279)-InVivo

製品コード：A2122         Batch: A212248

印刷

Anti-mouse PD-1 (CD279)-InVivo (Clone:RMP1-14)reacts with mouse PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily.

製品説明

Formulation PBS Buffer, PH 7.4
Clone RMP1-14
Isotype Rat IgG2a, κ
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C and avoid freeze-thaw cycle
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 6.86 mg/ml
Endotoxin Level ＜1EU/mg

カスタマーフィードバック

A2122-Anti-mouse PD-1 (CD279)-InVivo.gif

A2122-Anti-mouse PD-1 (CD279)-InVivo-2.gif

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma [ Signal Transduct Target Ther, 2025, 10(1):82] PubMed: 40032871
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance [ Signal Transduct Target Ther, 2025, 10(1):88] PubMed: 40102418
Nanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy [ ACS Nano, 2025, 19(14):13889-13905] PubMed: 40190094
The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy [ Nat Commun, 2025, 16(1):3855] PubMed: 40274828
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy [ Research (Wash D C), 2025, 8:0735] PubMed: 40530387
Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer [ J Immunother Cancer, 2025, 13(7)e011948] PubMed: 40664447
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-24-1194] PubMed: 40323348
Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation [ Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01507-9] PubMed: 40016522
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy [ J Transl Med, 2025, 23(1):453] PubMed: 40247265
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells [ J Transl Med, 2025, 23(1):164] PubMed: 39920704

人間や獣医の診断であるか治療的な使用のためにでない。